Portable lung perfusion device could revolutionise transplant procedures

October 9, 2012

Donor lungs are usually flushed and preserved at cold temperatures before transplantation. The cold temperature reduces tissue decomposition, but can also result in degradation of the organ and a longer transplantation process.

The newer process of normothermic perfusion – whereby the donor lung is flushed with a blood-like mixture of anti-rejection drugs, vitamins and hormones at a similar temperature to that of the human body internally, around 37oC – has the potential to greatly improve , as previous studies have shown that the lung suffers considerably less degradation through this process, compared to standard procedures. Normothermic perfusion also has the potential to renew suboptimal , therefore vastly expanding the pool of adequately-functioning donor lungs.

Until now, the only devices capable of performing normothermic perfusion have been static, which has limited the practical potential of the technique, since to maximise its , normothermic perfusion needs to take place as soon as possible after the donor lung becomes available. This limitation has also meant that large-scale, randomised, clinical trials of the technique have been difficult to set up.

However, the new study, conducted in Germany and Spain, tested the safety and efficacy of a portable normothermic perfusion device, called the portable Organ Care System (OCS), on a group of twelve . All twelve of the donor lungs in the trial were safely and effectively preserved using the device, which means that large-scale clinical trials can now take place to assess the performance of normothermic lung perfusion against standard cold-storage techniques.

According to one of the study's authors, Dr Gregor Warnecke at the Hanover Medical School in Germany, "Our first-in-man data for the use of the OCS lung in clinical transplantation provide the first evidence for good outcomes of in a high-risk patient population. This is, of course, a proof-of-concept study, and the effectiveness of the device will need to be proven in large-scale trials. But nonetheless, the results are very encouraging and we now look forward to undertaking further research on this exciting technique."

Another study author, Dr Javier Moradiellos at the Hospital Universitario Puerta de Hierro in Madrid, Spain, adds that, "These early data also show promising potential for OCS in the assessment of uncontrolled non-heart beating donors and in maintaining the viability of lungs for extended periods of time. The over-ten-hours preservation in one of the study subjects is the longest clinical ex vivo perfusion achieved to date."

Writing in a linked Comment, Dr Jose Borro at A Coruña University Hospital in Spain, adds, "The mobility of OCS Lung certainly brings about a reduction in cold ischaemia time and allows continuous monitoring of the process, and the device's portability will surely open new avenues for development of ex-vivo lung perfusion. The data in this study are promising, but we should be cautious in our expectations until the results of the ongoing large clinical trial are reported, which could confirm the efficacy and safety of this ex-vivo lung perfusion device."

Explore further: First US patient receives specially processed donor lungs at the University of Maryland

More information: www.thelancet.com/journals/lan … (12)61344-0/abstract

Related Stories

First US patient receives specially processed donor lungs at the University of Maryland

September 8, 2011
Surgeons at the University of Maryland Medical Center have transplanted the first lungs treated in the United States with an experimental repair process before transplantation. The procedure is part of a five-center national ...

Surgeons perform first 'ex vivo' lung transplants

December 12, 2011
A 59-year-old woman from upstate New York and a 60-year-old woman from the New York metro area were the first patients in New York state and among the first in the United States to receive transplanted lungs that were assessed ...

Recommended for you

Smoking raises risk of aneurysm recurrence after endovascular treatment

August 17, 2017
In a new study, researchers report people who have experienced an aneurysm have another reason to quit smoking.

Study adds to evidence that most prescribed opioid pills go unused

August 2, 2017
In a review of half a dozen published studies in which patients self-reported use of opioids prescribed to them after surgery, researchers at Johns Hopkins report that a substantial majority of patients used only some or ...

Engineers harness the power of 3-D printing to help train surgeons, shorten surgery times

August 2, 2017
A team of engineers and pediatric orthopedic surgeons are using 3D printing to help train surgeons and shorten surgeries for the most common hip disorder found in children ages 9 to 16. In a recent study, researchers showed ...

World's first child hand transplant a 'success'

July 19, 2017
The first child in the world to undergo a double hand transplant is now able to write, feed and dress himself, doctors said Tuesday, declaring the ground-breaking operation a success after 18 months.

Knee surgery—have we been doing it wrong?

July 18, 2017
A team of University at Buffalo medical doctors have published a study that challenges a surgical practice used for decades during arthroscopic knee surgery.

New tools help surgeons find liver tumors, not nick blood vessels

July 17, 2017
The liver is a particularly squishy, slippery organ, prone to shifting both deadly tumors and life-preserving blood vessels by inches between the time they're discovered on a CT scan and when the patient is lying on an operating ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.